{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:26:24Z","timestamp":1780093584111,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, we showed that combined intranasal and subcutaneous immunization with a non-replicating adenoviral vector expressing NP of influenza A, strain PR8, induced long-standing protection against a range of influenza A viruses. However, H-2<jats:sup>b<\/jats:sup> mice challenged with an influenza A strain mutated in the dominant NP<jats:sub>366<\/jats:sub> epitope were not efficiently protected. To address this problem, we envision the use of a cocktail of adenovectors targeting different internal proteins of influenza A virus. Consequently, we investigated the possibility of using PB1 as a target for an adenovector-based vaccine against influenza A. Our results showed that PB1 is not as immunogenic as the NP protein. However, by tethering PB1 to the murine invariant chain we were able to circumvent this problem and raise quite high numbers of PB1-specific CD8<jats:sup>+<\/jats:sup> T cells in the circulation. Nevertheless, mice immunized against PB1 were not as efficiently protected against influenza A challenge as similarly NP-vaccinated animals. The reason for this is not a difference in the quality of the primed cells, nor in functional avidity. However, under similar conditions of immunization fewer PB1-specific cells were recruited to the airways, and surface expression of the dominant PB1 peptide, PB1<jats:sub>703<\/jats:sub>, was less stable than in the case of NP<jats:sub>366<\/jats:sub>.<\/jats:p>","DOI":"10.1038\/srep35033","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T09:28:00Z","timestamp":1475832480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A"],"prefix":"10.1038","volume":"6","author":[{"given":"Ida E. M.","family":"Uddb\u00e4ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara R.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loulieta","family":"Nazerai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"BFsrep35033_CR1","unstructured":"http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/ World Health Organization. Influenza (Seasonal), 2014, Date of access:31-8-2016."},{"key":"BFsrep35033_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/CMR.00097-12","volume":"26","author":"SS Wong","year":"2013","unstructured":"Wong, S. S. & Webby, R. J. Traditional and new influenza vaccines. Clin. Microbiol. Rev. 26, 476\u2013492 (2013).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFsrep35033_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","volume":"33","author":"AF Altenburg","year":"2015","unstructured":"Altenburg, A. F., Rimmelzwaan, G. F. & de Vries, R. D. Virus-specific T cells as correlate of (cross-)protective immunity against influenza. Vaccine 33, 500\u2013506 (2015).","journal-title":"Vaccine"},{"key":"BFsrep35033_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/icb.2009.16","volume":"87","author":"LE Brown","year":"2009","unstructured":"Brown, L. E. & Kelso, A. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol. Cell Biol. 87, 300\u2013308 (2009).","journal-title":"Immunol. Cell Biol."},{"key":"BFsrep35033_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1084\/jem.20051365","volume":"202","author":"GJ de Bree","year":"2005","unstructured":"de Bree, G. J. et al. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J. Exp. Med. 202, 1433\u20131442 (2005).","journal-title":"J. Exp. Med."},{"key":"BFsrep35033_CR6","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.166.3.1813","volume":"166","author":"RJ Hogan","year":"2001","unstructured":"Hogan, R. J. et al. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166, 1813\u20131822 (2001).","journal-title":"J. Immunol."},{"key":"BFsrep35033_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S0140-6736(83)92297-3","volume":"2","author":"AJ McMichael","year":"1983","unstructured":"McMichael, A. J., Gotch, F. M., Dongworth, D. W., Clark, A. & Potter, C. W. Declining T-cell immunity to influenza, 1977-82. Lancet 2, 762\u2013764 (1983).","journal-title":"Lancet"},{"key":"BFsrep35033_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4049\/jimmunol.178.2.1030","volume":"178","author":"TJ Powell","year":"2007","unstructured":"Powell, T. J. et al. Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J. Immunol. 178, 1030\u20131038 (2007).","journal-title":"J. Immunol."},{"key":"BFsrep35033_CR9","doi-asserted-by":"publisher","first-page":"20137","DOI":"10.1038\/srep20137","volume":"6","author":"IE Uddback","year":"2016","unstructured":"Uddback, I. E. et al. Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus. Sci. Rep. 6, 20137 (2016).","journal-title":"Sci. Rep."},{"key":"BFsrep35033_CR10","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1128\/JVI.00465-13","volume":"87","author":"MA Steffensen","year":"2013","unstructured":"Steffensen, M. A. et al. Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation. J. Virol. 87, 6283\u20136295 (2013).","journal-title":"J. Virol."},{"key":"BFsrep35033_CR11","doi-asserted-by":"publisher","first-page":"e55435","DOI":"10.1371\/journal.pone.0055435","volume":"8","author":"A Vitelli","year":"2013","unstructured":"Vitelli, A. et al. Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus. PLoS. One. 8, e55435 (2013).","journal-title":"PLoS. One."},{"key":"BFsrep35033_CR12","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1016\/j.vaccine.2007.07.035","volume":"25","author":"S Roy","year":"2007","unstructured":"Roy, S. et al. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 25, 6845\u20136851 (2007).","journal-title":"Vaccine"},{"key":"BFsrep35033_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.virol.2010.05.002","volume":"405","author":"S Singh","year":"2010","unstructured":"Singh, S. et al. Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes. Virology 405, 62\u201369 (2010).","journal-title":"Virology"},{"key":"BFsrep35033_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00705-012-1238-6","volume":"157","author":"I Kosik","year":"2012","unstructured":"Kosik, I., Krejnusova, I., Praznovska, M., Polakova, K. & Russ, G. A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection. Arch. Virol. 157, 811\u2013817 (2012).","journal-title":"Arch. Virol."},{"key":"BFsrep35033_CR15","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.4049\/jimmunol.180.5.3339","volume":"180","author":"PJ Holst","year":"2008","unstructured":"Holst, P. J. et al. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines. J. Immunol. 180, 3339\u20133346 (2008).","journal-title":"J. Immunol."},{"key":"BFsrep35033_CR16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.4049\/jimmunol.1001251","volume":"186","author":"PJ Holst","year":"2011","unstructured":"Holst, P. J., Christensen, J. P. & Thomsen, A. R. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice. J. Immunol. 186, 3997\u20134007 (2011).","journal-title":"J. Immunol."},{"key":"BFsrep35033_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.0105-2896.2006.00385.x","volume":"211","author":"H Hikono","year":"2006","unstructured":"Hikono, H. et al. T-cell memory and recall responses to respiratory virus infections. Immunol. Rev. 211, 119\u2013132 (2006).","journal-title":"Immunol. Rev."},{"key":"BFsrep35033_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.171.1.27","volume":"171","author":"DL Barber","year":"2003","unstructured":"Barber, D. L., Wherry, E. J. & Ahmed, R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171, 27\u201331 (2003).","journal-title":"J. Immunol."},{"key":"BFsrep35033_CR19","unstructured":"http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/ World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO, 2016, Date of access: 31-8-0016."},{"key":"BFsrep35033_CR20","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.4049\/jimmunol.1301290","volume":"191","author":"S Jensen","year":"2013","unstructured":"Jensen, S. et al. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage. J. Immunol. 191, 4152\u20134164 (2013).","journal-title":"J. Immunol."},{"key":"BFsrep35033_CR21","doi-asserted-by":"publisher","first-page":"e27477","DOI":"10.1371\/journal.pone.0027477","volume":"6","author":"EZ Tchilian","year":"2011","unstructured":"Tchilian, E. Z. et al. Simultaneous immunization against tuberculosis. PLoS. One. 6, e27477 (2011).","journal-title":"PLoS. One."},{"key":"BFsrep35033_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.immuni.2014.06.007","volume":"41","author":"A Ballesteros-Tato","year":"2014","unstructured":"Ballesteros-Tato, A., Leon, B., Lee, B. O., Lund, F. E. & Randall, T. D. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells. Immunity. 41, 127\u2013140 (2014).","journal-title":"Immunity."},{"key":"BFsrep35033_CR23","doi-asserted-by":"publisher","first-page":"e8235","DOI":"10.1371\/journal.pone.0008235","volume":"4","author":"EO Ronan","year":"2009","unstructured":"Ronan, E. O., Lee, L. N., Beverley, P. C. & Tchilian, E. Z. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection. PLoS. One. 4, e8235 (2009).","journal-title":"PLoS. One."},{"key":"BFsrep35033_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.20022151","volume":"198","author":"SR Crowe","year":"2003","unstructured":"Crowe, S. R. et al. Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198, 399\u2013410 (2003).","journal-title":"J. Exp. Med."},{"key":"BFsrep35033_CR25","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/eji.201141546","volume":"41","author":"JE Suarez-Ramirez","year":"2011","unstructured":"Suarez-Ramirez, J. E. et al. Division of labor between subsets of lymph node dendritic cells determines the specificity of the CD8(+) T-cell recall response to influenza infection. Eur. J. Immunol. 41, 2632\u20132641 (2011).","journal-title":"Eur. J. Immunol."},{"key":"BFsrep35033_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/312548a0","volume":"312","author":"SP Cobbold","year":"1984","unstructured":"Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. & Waldmann, H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548\u2013551 (1984).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep35033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35033","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:23:05Z","timestamp":1672881785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep35033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep35033"],"URL":"https:\/\/doi.org\/10.1038\/srep35033","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]},"assertion":[{"value":"10 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Together with the University of Copenhagen and Peter J Holst, the authors JPC and ART hold a patent regarding the invariant chain fusion technology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35033"}}